Deloitte acquires healthcare data warehousing firm Recombinant; Internet-based therapy a viable treatment option for alcohol abusers;

> Pharmaceutical anti-counterfeiting technology will be a $1.2 billion worldwide market by 2015, according to a report published last week by London-based independent media company Visiongain. The introduction of industry-wide standards enforcing mandatory supply chain track-and-trace technologies will be a catalyst for the growth, according to pharmaceutical industry analyst Peter Williamson. Announcement

> Consulting company Deloitte this week announced the acquisition of healthcare data warehousing and analytics firm Recombinant Data Corp. Recombinant helps academic medical centers and federal agencies in conducting translational research and analyzing genomic data for the use of personalized medicine. Announcement

> Internet-based therapy for alcohol abusers is more effective than Internet-based self-help, according to research published this week in the Journal of Medical Internet Research. The study's authors suggest that Internet-based therapy could be considered a first-line treatment option in a matched-care approach. Study

And Finally… Fool me once, shame on you. Fool me 26 times … Article

Suggested Articles

With the promotion of Don Trigg, Cerner has named its first new president since 2018.

ONC head Donald Rucker, M.D. said Wednesday that regulators are trying to strike a balance between privacy and transparency with upcoming rule.

Executives are bullish on the potential of artificial intelligence to improve healthcare but think adoption needs to happen faster.